{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T01:20:01Z","timestamp":1769563201326,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Municipal Key Discipline","award":["2024ZDXK0016"],"award-info":[{"award-number":["2024ZDXK0016"]}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["No. 202140345"],"award-info":[{"award-number":["No. 202140345"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-33770-5","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:17:40Z","timestamp":1769113060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A nomogram prediction model incorporating noninvasive lens AGEs and conventional biochemical indicators for assessing and predicting diabetic kidney disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Lu-Lu","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Di","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Xuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"33770_CR1","unstructured":"Chinese Diabetes Society Microvascular Complications Group. Guideline for the prevention and treatment of diabetic kidney disease in China (2021 edition). Chin. J. Diabetes Mellitus 13, 762\u2013784 (2021)."},{"key":"33770_CR2","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens, P. E. et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105, S117\u2013S314 (2024).","journal-title":"Kidney Int."},{"key":"33770_CR3","doi-asserted-by":"publisher","first-page":"892070","DOI":"10.3389\/fendo.2022.892070","volume":"13","author":"X-M Zhang","year":"2022","unstructured":"Zhang, X.-M. et al. Exploration of noninvasive detection of advanced glycation end products in the lens to screen for diabetic kidney disease. Front. Endocrinol. 13, 892070 (2022).","journal-title":"Front. Endocrinol."},{"key":"33770_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441","author":"RD Riley","year":"2020","unstructured":"Riley, R. D. et al. Calculating the sample size required for developing a clinical prediction model. BMJ https:\/\/doi.org\/10.1136\/bmj.m441 (2020).","journal-title":"BMJ"},{"key":"33770_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1053\/j.ajkd.2020.01.019","volume":"76","author":"B Kwan","year":"2020","unstructured":"Kwan, B. et al. Metabolomic markers of kidney function decline in patients with diabetes: Evidence from the chronic renal insufficiency cohort (CRIC) study. Am. J. Kidney Dis. 76, 511\u2013520 (2020).","journal-title":"Am. J. Kidney Dis."},{"key":"33770_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s40618-022-01919-y","volume":"46","author":"SM Hosseini Sarkhosh","year":"2022","unstructured":"Hosseini Sarkhosh, S. M., Hemmatabadi, M. & Esteghamati, A. Development and validation of a risk score for diabetic kidney disease prediction in type 2 diabetes patients: a machine learning approach. J Endocrinol Invest 46, 415\u2013423 (2022).","journal-title":"J Endocrinol Invest"},{"key":"33770_CR7","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.2147\/IJGM.S449397","volume":"17","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Design of machine learning algorithms and internal validation of a kidney risk prediction model for type 2 diabetes mellitus. IJGM 17, 2299\u20132309 (2024).","journal-title":"IJGM"},{"key":"33770_CR8","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.2147\/DMSO.S458263","volume":"17","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. Machine learning-based predictive modeling of diabetic nephropathy in type 2 diabetes using integrated biomarkers: A Single-center retrospective study. DMSO 17, 1987\u20131997 (2024).","journal-title":"DMSO"},{"key":"33770_CR9","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.3390\/ijms21124236","volume":"21","author":"H-S Ahn","year":"2020","unstructured":"Ahn, H.-S. et al. Differential urinary proteome analysis for predicting prognosis in type 2 diabetes patients with and without renal dysfunction. IJMS 21, 4236 (2020).","journal-title":"IJMS"},{"key":"33770_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6672444","volume":"2021","author":"C Xi","year":"2021","unstructured":"Xi, C., Wang, C., Rong, G. & Deng, J. A nomogram model that predicts the risk of diabetic nephropathy in type 2 diabetes mellitus patients: A retrospective study. Int. J. Endocrinol. 2021, 1\u20139 (2021).","journal-title":"Int. J. Endocrinol."},{"key":"33770_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2147\/DMSO.S442925","volume":"17","author":"X Wang","year":"2024","unstructured":"Wang, X., Liu, X., Zhao, J., Chen, M. & Wang, L. Construction of a nomogram-based prediction model for the risk of diabetic kidney disease in T2DM. DMSO 17, 215\u2013225 (2024).","journal-title":"DMSO"},{"key":"33770_CR12","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2337\/dc19-1897","volume":"43","author":"W Jiang","year":"2020","unstructured":"Jiang, W. et al. Establishment and validation of a risk prediction model for early diabetic kidney disease based on a systematic review and meta-analysis of 20 cohorts. Diabetes Care 43, 925\u2013933 (2020).","journal-title":"Diabetes Care"},{"key":"33770_CR13","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2147\/DMSO.S244061","volume":"13","author":"R Shi","year":"2020","unstructured":"Shi, R. et al. Nomogram for the risk of diabetic nephropathy or diabetic retinopathy among patients with type 2 diabetes mellitus based on questionnaire and biochemical indicators: A cross-sectional study. DMSO 13, 1215\u20131229 (2020).","journal-title":"DMSO"},{"key":"33770_CR14","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2147\/DMSO.S357357","volume":"15","author":"D Zhou","year":"2022","unstructured":"Zhou, D., Wei, J., Zhang, T., Shen, F. & Yang, J.-K. Establishment and validation of a nomogram model for prediction of diabetic nephropathy in type 2 diabetic patients with proteinuria. DMSO 15, 1101\u20131110 (2022).","journal-title":"DMSO"},{"key":"33770_CR15","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2337\/dc23-2364","volume":"47","author":"D He","year":"2024","unstructured":"He, D. et al. The difference between cystatin C- and creatinine-based estimated glomerular filtration rate and risk of diabetic microvascular complications among adults with diabetes: A population-based cohort study. Diabetes Care 47, 873\u2013880 (2024).","journal-title":"Diabetes Care"},{"key":"33770_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1080\/0886022X.2022.2056053","volume":"44","author":"Y Zou","year":"2022","unstructured":"Zou, Y. et al. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease. Ren. Fail. 44, 562\u2013570 (2022).","journal-title":"Ren. Fail."},{"key":"33770_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/jpm13030556","volume":"13","author":"S Ding","year":"2023","unstructured":"Ding, S. et al. Diagnostic value of the combined measurement of serum HCY and NRG4 in type 2 diabetes mellitus with early complicating diabetic nephropathy. JPM 13, 556 (2023).","journal-title":"JPM"},{"key":"33770_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/407452","volume":"2013","author":"T Wang","year":"2013","unstructured":"Wang, T., Wang, Q., Wang, Z., Xiao, Z. & Liu, L. Diagnostic value of the combined measurement of serum Hcy, Serum Cys C, and urinary microalbumin in type 2 diabetes mellitus with early complicating diabetic nephropathy. ISRN Endocrinology 2013, 1\u20135 (2013).","journal-title":"ISRN Endocrinology"},{"key":"33770_CR19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1001\/jama.2022.12407","volume":"328","author":"MG Shlipak","year":"2022","unstructured":"Shlipak, M. G., Inker, L. A. & Coresh, J. Serum cystatin C for estimation of GFR. JAMA 328, 883 (2022).","journal-title":"JAMA"},{"key":"33770_CR20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1159\/000452593","volume":"41","author":"B Zhou","year":"2016","unstructured":"Zhou, B., Zou, H. & Xu, G. Clinical utility of serum cystatin C in predicting diabetic nephropathy among patients with diabetes mellitus: A meta-analysis. Kidney Blood Press Res 41, 919\u2013928 (2016).","journal-title":"Kidney Blood Press Res"},{"issue":"04","key":"33770_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-2004-817933","volume":"112","author":"SA Aksun","year":"2004","unstructured":"Aksun, S. A. et al. \u03b22-microglobulin and cystatin C in Type 2 diabetes: Assessment of diabetic nephropathy. Exp. Clinic. Endocrinol. Diabetes 112(04), 195\u2013200 (2004).","journal-title":"Exp. Clinic. Endocrinol. Diabetes"},{"issue":"2","key":"33770_CR22","first-page":"241","volume":"63","author":"H Chen","year":"2017","unstructured":"Chen, H. & Li, H. Clinical implication of cystatin C and \u03b22-microglobulin in early detection of diabetic nephropathy. Clinic. Lab. 63(2), 241\u2013247 (2017).","journal-title":"Clinic. Lab."},{"key":"33770_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/407452","volume":"2013","author":"T Wang","year":"2013","unstructured":"Wang, T., Wang, Q., Wang, Z., Xiao, Z. & Liu, L. Diagnostic value of the combined measurement of serum Hcy, serum Cys C, and urinary microalbumin in type 2 diabetes mellitus with early complicating diabetic nephropathy. ISRN Endocrinol. 2013, 1\u20135 (2013).","journal-title":"ISRN Endocrinol."},{"key":"33770_CR24","doi-asserted-by":"publisher","first-page":"102882","DOI":"10.1016\/j.dsx.2023.102882","volume":"17","author":"K Xiong","year":"2023","unstructured":"Xiong, K. et al. Serum cystatin C for risk stratification of prediabetes and diabetes populations. Diabetes Metab. Syndr. 17, 102882 (2023).","journal-title":"Diabetes Metab. Syndr."},{"key":"33770_CR25","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3390\/ijms23031288","volume":"23","author":"OM Belali","year":"2022","unstructured":"Belali, O. M. et al. LCZ696 Protects against Diabetic Cardiomyopathy-Induced Myocardial Inflammation, ER Stress, and Apoptosis through Inhibiting AGEs\/NF-\u03baB and PERK\/CHOP Signaling Pathways. IJMS 23, 1288 (2022).","journal-title":"IJMS"},{"key":"33770_CR26","doi-asserted-by":"publisher","first-page":"7202","DOI":"10.1038\/s41598-025-88806-7","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. The role of advanced glycation end products between thyroid function and diabetic nephropathy and metabolic disorders. Sci. Rep. 15, 7202 (2025).","journal-title":"Sci. Rep."},{"key":"33770_CR27","first-page":"396","volume":"43","author":"Y Gao","year":"2023","unstructured":"Gao, Y. et al. Study on the relationship between non-invasive measurement of advanced glycation end products in the lens and different renal injury assessment systems in patients with type 2 diabetic nephropathy. Chin. J. Pract. Intern. Med. 43, 396\u2013400 (2023).","journal-title":"Chin. J. Pract. Intern. Med."},{"key":"33770_CR28","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3390\/ijms24032927","volume":"24","author":"T Oshitari","year":"2023","unstructured":"Oshitari, T. Advanced glycation end-products and diabetic neuropathy of the retina. IJMS 24, 2927 (2023).","journal-title":"IJMS"},{"key":"33770_CR29","doi-asserted-by":"publisher","first-page":"103246","DOI":"10.1016\/j.redox.2024.103246","volume":"75","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la\/KLF5 pathway. Redox Biol. 75, 103246 (2024).","journal-title":"Redox Biol."},{"key":"33770_CR30","doi-asserted-by":"publisher","first-page":"1307837","DOI":"10.3389\/fendo.2024.1307837","volume":"15","author":"Y Jiang","year":"2024","unstructured":"Jiang, Y., Liu, X., Gao, H., Yan, J. & Cao, Y. A new nomogram model for the individualized prediction of mild cognitive impairment in elderly patients with type 2 diabetes mellitus. Front. Endocrinol. 15, 1307837 (2024).","journal-title":"Front. Endocrinol."},{"key":"33770_CR31","doi-asserted-by":"publisher","first-page":"864562","DOI":"10.3389\/fendo.2022.864562","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. High normal urinary albumin-creatinine ratio is associated with hypertension, type 2 diabetes mellitus, HTN with T2DM, dyslipidemia, and cardiovascular diseases in the Chinese population: a report from the REACTION study. Front. Endocrinol. 13, 864562 (2022).","journal-title":"Front. Endocrinol."},{"key":"33770_CR32","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1111\/dom.14449","volume":"23","author":"SL Atkin","year":"2021","unstructured":"Atkin, S. L., Butler, A. E., Hunt, S. C. & Kilpatrick, E. S. The retinopathy-derived HbA1c threshold of 6.5% for type 2 diabetes also captures the risk of diabetic nephropathy in NHANES. Diabetes Obesity Metabolism 23, 2109\u20132115 (2021).","journal-title":"Diabetes Obesity Metabolism"},{"key":"33770_CR33","first-page":"1","volume":"2020","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Poor control of plasma triglycerides is associated with early decline of estimated glomerular filtration rates in new-onset type 2 diabetes in China: results from a 3-year follow-up study. J. Diabetes Res. 2020, 1\u20138 (2020).","journal-title":"J. Diabetes Res."},{"key":"33770_CR34","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1111\/dom.14502","volume":"23","author":"L Gong","year":"2021","unstructured":"Gong, L. et al. High concentrations of triglycerides are associated with diabetic kidney disease in new-onset type 2 diabetes in C hina: Findings from the C hina C ardiometabolic D isease and C ancer C ohort (4C ) S tudy. Diabetes Obesity Metabolism 23, 2551\u20132560 (2021).","journal-title":"Diabetes Obesity Metabolism"},{"key":"33770_CR35","doi-asserted-by":"publisher","first-page":"e130317","DOI":"10.1172\/jci.insight.130317","volume":"4","author":"F Afshinnia","year":"2019","unstructured":"Afshinnia, F. et al. Increased lipogenesis and impaired \u03b2-oxidation predict type 2 diabetic kidney disease progression in American Indians. JCI Insight 4, e130317 (2019).","journal-title":"JCI Insight"},{"key":"33770_CR36","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S43211","author":"Z-S Wang","year":"2013","unstructured":"Wang, Z.-S. et al. Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus. VHRM https:\/\/doi.org\/10.2147\/VHRM.S43211 (2013).","journal-title":"VHRM"},{"key":"33770_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12902-024-01766-3","volume":"24","author":"W Sun","year":"2024","unstructured":"Sun, W. et al. Increased risk of vascular complications in patients with type 2 diabetes and fatty liver disease. BMC Endocr Disord 24, 235 (2024).","journal-title":"BMC Endocr Disord"},{"key":"33770_CR38","doi-asserted-by":"publisher","first-page":"29288","DOI":"10.1038\/s41598-024-80797-1","volume":"14","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. Red blood cell count and cystatin C as the specific biomarkers for diabetic retinopathy from diabetes mellitus: A case\u2013control study. Sci Rep 14, 29288 (2024).","journal-title":"Sci Rep"},{"key":"33770_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41387-024-00297-z","volume":"14","author":"X Zheng","year":"2024","unstructured":"Zheng, X. et al. Vitamin D is involved in the effects of the intestinal flora and its related metabolite TMAO on perirenal fat and kidneys in mice with DKD. Nutr. Diabetes 14, 42 (2024).","journal-title":"Nutr. Diabetes"},{"key":"33770_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/jpgm.JPGM_598_16","volume":"64","author":"P Liyanage","year":"2018","unstructured":"Liyanage, P., Lekamwasam, S., Weerarathna, T. & Liyanage, C. Effect of Vitamin D therapy on urinary albumin excretion, renal functions, and plasma renin among patients with diabetic nephropathy: A randomized, double-blind clinical trial. J. Postgrad. Med. 64, 10\u201315 (2018).","journal-title":"J. Postgrad. Med."},{"key":"33770_CR41","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00384-020-03576-0","volume":"35","author":"V Domazetovic","year":"2020","unstructured":"Domazetovic, V., Iantomasi, T., Bonanomi, A. G. & Stio, M. Vitamin D regulates claudin-2 and claudin-4 expression in active ulcerative colitis by p-Stat-6 and Smad-7 signaling. Int J Colorectal Dis 35, 1231\u20131242 (2020).","journal-title":"Int J Colorectal Dis"},{"key":"33770_CR42","doi-asserted-by":"publisher","first-page":"100531","DOI":"10.1016\/j.jbc.2021.100531","volume":"296","author":"M Yu","year":"2021","unstructured":"Yu, M. et al. Vitamin D receptor inhibits EMT via regulation of the epithelial mitochondrial function in intestinal fibrosis. J. Biol. Chem. 296, 100531 (2021).","journal-title":"J. Biol. Chem."},{"key":"33770_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41387-023-00238-2","volume":"13","author":"CS Souza","year":"2023","unstructured":"Souza, C. S. et al. Vitamin D deficiency contributes to the diabetic kidney disease progression via increase ZEB1\/ZEB2 expressions. Nutr. Diabetes 13, 9 (2023).","journal-title":"Nutr. Diabetes"},{"key":"33770_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jare.2020.07.007","volume":"28","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Quercetin alleviates acute kidney injury by inhibiting ferroptosis. J. Adv. Res. 28, 231\u2013243 (2021).","journal-title":"J. Adv. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33770-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33770-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33770-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:03:55Z","timestamp":1769515435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33770-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33770"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33770-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3653"}}